Emily Elizabeth Baldwin, Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-662-4000 |
Victoria Lynn Alvarez, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-662-4000 |
Angelica Rosello Arias, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-662-4000 |
News Archive
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
While researching methods to increase the already well-recognized anti-cancer properties of broccoli, researchers at the University of Illinois also found a way to prolong the vegetable's shelf life.
A widely used class of diabetes medications appears to be associated with an increased risk for fractures, according to a report in the April 28 issue of Archives of Internal Medicine.
Boston Scientific Corporation today announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company's fourth-generation SYNERGY™ Coronary Stent. The randomized, single-blind, non-inferiority trial will compare the SYNERGY Stent to the PROMUS Element™ Everolimus-Eluting Coronary Stent in patients with a single de novo native coronary artery lesion.
› Verified 7 days ago